SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025043
Filing Date
2020-05-13
Accepted
2020-05-13 16:05:27
Documents
45
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alec-10q_20200331.htm 10-Q 1739290
2 EX-31.1 alec-ex311_7.htm EX-31.1 18755
3 EX-31.2 alec-ex312_9.htm EX-31.2 18743
4 EX-32.1 alec-ex321_6.htm EX-32.1 9482
5 EX-32.2 alec-ex322_8.htm EX-32.2 9518
  Complete submission text file 0001564590-20-025043.txt   4456730

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alec-20200331.xml EX-101.INS 706274
7 XBRL TAXONOMY EXTENSION SCHEMA alec-20200331.xsd EX-101.SCH 28522
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alec-20200331_cal.xml EX-101.CAL 32978
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alec-20200331_def.xml EX-101.DEF 104562
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20200331_lab.xml EX-101.LAB 278269
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20200331_pre.xml EX-101.PRE 201117
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 20873174
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences